Venus Concept Inc.

VERO

NASDAQ · Medical Devices

$0.27

At close - Aug 4, 4:00 PM EDT - USD

Market Cap$498989

P/E-0.0x

52W High$12.93

Volume43

VCP Research Verdict2025Q3

Persistent Revenue Contraction Signals Structural Liquidity Crisis

Venus Concept faces a severe fundamental deterioration characterized by consistent top-line erosion and an inability to scale its operating infrastructure, as evidenced by a -68.9% operating margin in 2025Q3. The company's reliance on debt financing, now refle...

GrowthContracting

ProfitabilityNegative

ValuationReview

TechnicalsWeak

Explore valuation models

MARKET ACTION

VERO price & volume

Price trend, volume and key moving averages

Launch Terminal

Loading chart...

Market performance

Price History →

Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return

VERO-79.54%

S&P 500 (^GSPC)+12.39%

1-Year Return

VERO-86.59%

S&P 500 (^GSPC)+15.77%

3-Year Return

VERO-98.65%

S&P 500 (^GSPC)+77.13%

5-Year Return

VERO-99.93%

S&P 500 (^GSPC)+71.75%

Growth & profitability

Annual revenue & EPS trend

Revenue

$65M-15.1% YoY

Net income

-$47M-26.2% YoY

Free cash flow

-$11M+13.8% YoY

Operating margin

-41.9%-4.9 pts YoY

ROIC (TTM)-39.8%

Avg ROIC 5Y-

ROE (TTM)-1656%

Piotroski Score5 / 9

Financial Statements →

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

MARKET COVERAGE

Latest News

1 Stories

GlobeNewsWire·Jul 28, 2026

Venus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and Canada

TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC's Doublo 2.0 device in the United States and Canada.

Filtered for Venus Concept Inc.More Headlines

Compare before deciding

Benchmark VERO against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Venus Concept Inc. (VERO)

Full Screener →

Company	Price	Market Cap	P/E Ratio	Rev Growth (1Y)	Net Margin	ROE	Div Yield
VEROVenus Concept Inc.Current	$0.27	$498.99K	-0.00	-15.09%	-72.49%	-1655.95%	—
INMDInMode Ltd.	$14.19	$815.65M	9.92	-6.16%	20.69%	11.8%	—
SSKNSTRATA Skin Sciences, Inc.	$0.01	$29.44K	-0.00	-8.54%	-21.13%	-360.33%	—
LASELaser Photonics Corporation	$0.87	$41.4M	-0.85	131.96%	-327.57%	—	—
HIMSHims & Hers Health, Inc.	$28.39	$6.33B	55.67	59%	-5.51%	-30.03%	—
SKINSkinHealth Systems Inc.	$0.68	$87.7M	-4.23	-10.02%	-9.79%	-47.84%	—

Compare VERO vs Peers

Venus Concept Inc. (VERO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs INMD

Most directly comparable listed peer for VERO.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare VERO against a more recognizable public peer.

Peer Set

Compare Top 5

vs INMD, SSKN, LASE, HIMS

Get notified when VERO posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

VERO Frequently Asked Questions

Venus Concept Inc. (VERO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

What is Venus Concept Inc.'s revenue?

Venus Concept Inc. (VERO) reported $58.9M in revenue for fiscal year 2024. This represents a 242% increase from $17.2M in 2015.

How fast is Venus Concept Inc. growing?

Venus Concept Inc. (VERO) saw revenue decline by 15.1% over the past year.

Is VERO profitable?

Venus Concept Inc. (VERO) reported a net loss of $54.6M for fiscal year 2024.

Dividend & Returns

What is VERO's return on equity?

Venus Concept Inc. (VERO) has a return on equity (ROE) of -1656.0%. Negative ROE indicates the company is unprofitable.

What is Venus Concept Inc.'s free cash flow?

Venus Concept Inc. (VERO) had negative free cash flow of $20.7M in fiscal year 2024, likely due to heavy capital investments.

What if you invested $1,000 in VERO back in 2015?

Total return calculator · dividends reinvested · 11+ years of data

See returns →

Company

Price

Market Cap

P/E Ratio

Rev Growth (1Y)

Net Margin

ROE

Div Yield

VEROVenus Concept Inc.Current

$0.27

$498.99K

-0.00

-15.09%

-72.49%

-1655.95%

—

INMDInMode Ltd.

$14.19

$815.65M

9.92

-6.16%

20.69%

11.8%

—

SSKNSTRATA Skin Sciences, Inc.

$0.01

$29.44K

-0.00

-8.54%

-21.13%

-360.33%

—

LASELaser Photonics Corporation

$0.87

$41.4M

-0.85

131.96%

-327.57%

—

HIMSHims & Hers Health, Inc.

$28.39

$6.33B

55.67

59%

-5.51%

-30.03%

—

SKINSkinHealth Systems Inc.

$0.68

$87.7M

-4.23

-10.02%

-9.79%

-47.84%

—